Abilify
Product Images NDC 52959-604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abilify (NDC 52959-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Estimation Of Proportion Of Relapses To Any Mood Event For Abilify And Placebo Groups (Abilify Image11 Figure1)

FDA Label Image

Aripiprazole Chemical Structure (Abilify Structure)

FDA Label Image

Abilify 5-mg Tablets (Abilify Tab Image02 5mg)

Abilify 5-mg Tablets (Abilify Tab Image02 5mg)
This is a description of a medication called Abilify. The medication is in the form of blue rectangular tablets with a pill ID number of 52959-604-30. The manufacturing lot number is ABF5010Q and it was produced by OtsukaPhar in Tokyo, Japan. The medication has an expiration date of 08/12. The tablets are only available with a prescription from a doctor and the usual dosage information can be found in the insert. There is a warning on the packaging that prohibits the transfer of the medication to others and advises to keep it in a safe place.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.